Abstract:OBJECTIVE:To explore the synergistic anti-tumor effect of radiotherapy and horseradish peroxidase/prodrug indole-3-acetic acid (HRP/IAA) gene therapy system using chimeric hTERT promoter responsive to ionizing radiation.METHODS:The synthetic hTERT promoters containing four tandem-repeat copies of radio-inducible CArG elements, and the chimeric promoter containing cytomegalovirus (CMV) early promoter were both constructed. The activities of the chimeric promoters in cancer cell lines (HeLa, A549, and MHCC97) and normal cell line (MRC-5) were detected using luciferase reporter gene expression analysis after a (60)Co γ-irradiation treatment at a series of doses(a single dose of 0 to 10 Gy). The anti-tumor effect of combining irradiation with HRP/IAA gene-directed enzyme prodrug therapy system controlled by the chimeric promoter was tested by colony formation assay, cell counting and apoptosis analysis.RESULTS:The chimeric promoters were ineffective in normal human cells, even after irradiation, but the expression of luciferase gene in tumor cells was significantly higher. The activity of the chimeric promoter in MRC-5 cells was 22.3%, 12.9% and 13.6% of that in HeLa, A549 and MHCC97 cells, respectively. After irradiation, the ratios were 11.7%, 8.7% and 8.8%, respectively. Furthermore, the chimeric promoters could successfully induce the expression of luciferase gene following different doses of radiation, with maximal inducible activity seen after 6 Gy irradiation. The chimeric promoter containing four tandem-repeat copies of radio-inducible CArG elements and CMV early promoter showed the highest activity with 6 Gy irradiation. The relative luciferase activities in HeLa, A549 and MHCC97 cells were 1.7 ± 0.2, 2.3 ± 0.2 and 2.3 ± 0.1, respectively. The chimeric promoter mediated suicide gene therapy system could increase radio-sensitivity in different cancer cells. Compared with the control system, it plus irradiation showed stronger cell proliferation inhibition, 67.3% vs. 26.1% in HeLa, 69.0% vs. 28.3% in A549, 64.6% vs. 20.8% in MHCC97 cells, and also higher apoptosis-inducing effect, 39.6% vs. 14.2% in HeLa, 33.0% vs. 12.4% in A549, and 33.2% vs. 14.2% in MHCC97 cells.CONCLUSIONS:Chimeric promoter containing hTERT promoter, CArG elements and CMV promoter preserve the tumor-specificity in telomerase-positive tumor cells, and irradiation-responsive to low dose of radiation. The suicide gene therapy using this promoter plus radiotherapy show a strong anti-tumor effect in vitro. It is expected to have a good potential for future application in gene radiotherapy.

Progress of Hypoxia/radiation Dual-sensitive Promoter Controlling Suicide Gene Expression in Radiotherapy

Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation

[Anti-Tumor Effect of Suicide Gene Therapy Using Chimeric Promoter Plus Radiotherapy on Cancer Cell Lines].

Development of Chimeric Gene Promoters Responsive to Hypoxia and Ionizing Radiation

Novel, Chimeric, Cancer-Specific, and Radiation-Inducible Gene Promoters for Suicide Gene Therapy of Cancer.

Hypoxia Targeted Bifunctional Suicide Gene Expression Enhances Radiotherapy in Vitro and in Vivo.

Radiation Enhances Suicide Gene Therapy in Radioresistant Laryngeal Squamous Cell Carcinoma Via Activation of A Tumor-Specific Promoter

Radiobiology Effects of Radiation-Induced Horseradish Peroxidase/indole-3-acetic Suicide Gene Expression in Lung Cancer Cells

Hypoxia-targeted Triple Suicide Gene Therapy Radiosensitizes Human Colorectal Cancer Cells

Abstract 2051: Hypoxia-induced Triple Suicide Gene TK/CD/UPRT Expression Enhances Cytotoxicity to GCV and 5-FC and Radiosensitization in Human Colorectal Cancer Cells

Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy.

How to overcome (and exploit) tumor hypoxia for targeted gene therapy

4:10 PM Abstract No. 50 Intratumoral Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene Therapy of Orthotopic Lung Cancer Through the Augmentation of Apoptosis and Heat Shock Protein (HSP70) Expression Pathway

The Progress of Tumor Gene-Radiotherapy Induced by Egr-1 Promoter

Hypoxia/radiation dual-sensitive promoters enhance the toxicity of HSVtk-mediated gene-directed enzyme prodrug therapy in Lung Cancer Cells

Recent Progress in Nano-biomaterials for Tumor Hypoxia Relief and Enhanced Cancer Radiotherapy

[Radiosensitization by double suicide gene system in ACC-2 cell].

Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy

Radiation-/hypoxia-induced Solid Tumor Metastasis and Regrowth Inhibited by Hypoxia-Specific Upconversion Nanoradiosensitizer

In Vivo Experimental Study on Nasopharyngeal Carcinoma with Combination of Padkdr-Tk/gcv Suicide Gene Therapysystem and 60co Radiotherapy

The combination of suicide gene therapy and radiation enhances the killing of nasopharyngeal carcinoma xenographs